L Vincent
Overview
Explore the profile of L Vincent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vincent L, Robard L, Creveuil C, Babin E, Perreard M, Humbert M
Eur Ann Otorhinolaryngol Head Neck Dis
. 2024 Nov;
142(2):67-73.
PMID: 39510938
Objective: The main objective was to determine the minimum effective dose of bevacizumab by intranasal spray to treat epistaxis in OWRD: i.e., the dose resulting in≥50% reduction in the number...
2.
Chalopin T, Macro M, Decaux O, Royer B, Gounot R, Bobin A, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Oct;
25(2):e103-e109.e1.
PMID: 39462749
Introduction: Multiple myeloma patients aged 80 years and older are a population more prone to comorbidities and frailty. We aim to describe the real-life management and outcomes of this population....
3.
Li A, Hauge H, Verheijen M, Bakkers E, Tucker R, Vincent L, et al.
Nanotechnology
. 2024 Jul;
35(37).
PMID: 38949609
No abstract available.
4.
Ferment B, Lambert J, Caillot D, Lafon I, Karlin L, Lazareth A, et al.
Br J Haematol
. 2024 May;
205(3):990-998.
PMID: 38747092
Idecabtagene vicleucel (ide-cel), a chimeric antigen receptor T-cell therapy targeting B-cell maturation antigen (BCMA), received early access program (EAP) authorization in France in April 2021 for relapsed/refractory multiple myeloma (RRMM)....
5.
Macro M, Hulin C, Vincent L, Charvet-Rumpler A, Benboubker L, Calmettes C, et al.
Ann Hematol
. 2023 Jun;
102(8):2137-2151.
PMID: 37301786
Ixazomib (IXA) is an oral proteasome inhibitor (PI) used in combination with lenalidomide and dexamethasone (IXA-Rd) for patients with relapsed and/or refractory multiple myeloma (RRMM). The REMIX study is one...
6.
Li A, Hauge H, Verheijen M, Bakkers E, Tucker R, Vincent L, et al.
Nanotechnology
. 2022 Sep;
34(1).
PMID: 36126589
Hexagonal SiGe-2H has been recently shown to have a direct bandgap, and holds the promise to be compatible with silicon technology. Hexagonal Si and Ge have been grown on an...
7.
Fauconnier M, Burnier P, Jankowski C, Loustalot C, Coutant C, Vincent L
J Plast Reconstr Aesthet Surg
. 2022 Sep;
75(10):3653-3663.
PMID: 36100540
Introduction: Breast reconstruction is becoming increasingly important in the management of breast cancer. Among breast reconstruction with flap, latissimus dorsi flap is the most frequent technique used in France. Lipofilling's...
8.
Vincent L, Jankowski C, Ouldamer L, Ballester M, Bendifallah S, Bolze P, et al.
Eur J Surg Oncol
. 2020 May;
46(9):1689-1696.
PMID: 32417154
Introduction: The aim of this study was to identify prognostic factors of overall survival in patients with FIGO stage IIIc or IVa ovarian cancer (OC) treated by neo-adjuvant chemotherapy (NAC)...
9.
Vincent L, Jankowski C, Arnould L, Coudert B, Rouzier R, Reyal F, et al.
Gynecol Obstet Fertil Senol
. 2020 Mar;
48(9):679-686.
PMID: 32205278
Objectives: The aim of this study was to compare the value of F-fluorodesoxyglucose positron emission tomography (F-FDG PET/CT) with CGFL/Curie nomogram to predict a pathologic complete response (pCR) after neoadjuvant...
10.